Why Florida wants companies to turn over personal data about customers’ prescriptions
What is it that the PBM industry doesn’t want you to know?” asked the CEO of the Florida Pharmacy Association.
BenefitsPRO8h
'Fully transparent' PBMs may not cut costs, Segal health expert says
Ed Kaplan, the national health practice leader at Segal, also has concerns about "any willing provider" strategies.
Becker's Hospital Review9h
Drug shortages could surge 25% as AI reshapes specialty pharmacy: Survey
Another pressing concern for participants was the rise in drug costs, with 54% expecting at least half of U.S. states to establish drug-affordability boards. Additionally, 97% foresee a 25% surge in ...
The Commonwealth Fund15h
What Pharmacy Benefit Managers Do, and How They Contribute to Drug Spending
Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...
PharmExec17h
Applying Porter’s Five Forces to Portfolio Management in Pharmaceutical R&D: A Strategic Roadmap
The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...
Minoxidil (5% & 2%) Strategic Research Report 2025: Global Market to Grow by $300 Million to 2030 - Expanding E-Commerce Channels Propel Expansion
Understand the significant growth trajectory of the Minoxidil 5% segment, which is expected to reach US$1.6 Billion by 2030 ...